Replies to post #5233 on Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

I can't add anything new.....I'm just referencing what we already know that has been posted here.

Lunacy's recent post is a powerful testament:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133929107

I'm in repetition mode here, but the short list of AUPH's advantages are:

Stellar management team, great science, Aspreva success, stellar VOC P2 results, expertise in trial design, FDA Fast Track status, etc.

I simply believe that when you add it all up, it significantly boosts their odds of success in P3.